Company News /
by Rachael Jones -
2 months ago
07 Oct 2019 - Telix Pharmaceuticals (ASX:TLX) today announced that Dr David Cade has joined the Telix executive leadership team in the role of Chief Business Officer and Head of In…
Company News /
by Rachael Jones -
2 months ago
03 Oct 2019 - Telix Pharmaceuticals (ASX:TLX) has entered into a conditional purchase agreement with technology giant Eckert & Ziegler to acquire a radiopharmaceutical production f…
Interviews /
by Anna Napoli -
6 months ago
30 May 2019 - Telix Pharmaceuticals Limited (ASX:TLX) CEO, Dr Christian Behrenbruch discusses the company’s development pipeline and the benefits of using its diagnostic and therap…
Company Presentations /
by -
6 months ago
30 May 2019 - Telix Pharmaceuticals Limited (ASX:TLX) CEO, Dr Christian Behrenbruch discusses the company’s development pipeline and the benefit of diagnostic and therapeutic produ…
Company News /
by Katrina Bullock -
7 months ago
26 Apr 2019 - Telix Pharmaceuticals (ASX:TLX) has announced that phase two of its prostate drug clinical data demonstrates that low, repeated doses significantly reduce hematologic…
Market Reports /
by Rachael Jones -
10 months ago
24 Jan 2019 - The ASX opened higher and is now tracking 0.2% higher at noon. Santos (ASX:STO) stock is one of the best performers today after announcing their record quarterly sale…
Market Reports /
by Anna Napoli -
11 months ago
08 Jan 2019 - Australian shares are expected to edge higher this morning following a rally on Wall Street. Biotech company, Telix Pharmaceuticals (ASX:TLX) has announced the accele…
Company News /
by Rachael Jones -
A year ago
10 Oct 2018 - Biopharmaceutical company Telix Pharmaceuticals (ASX:TLX) has entered into a strategic collaboration agreement with GenesisCare, the largest private provider of oncol…
Company News /
by Anna Napoli -
A year ago
11 Sep 2018 - Telix Pharmaceuticals (ASX:TLX) has today announced the completion of its acquisition of Atlab Pharma.
Company News /
by Anna Napoli -
A year ago
04 Sep 2018 - Biopharmaceutical company, Telix (ASX:TLX) has secured ethics approval to commence a Phase1/11 study for the use of its drug to treat recurrent glioblastoma.
Company News /
by Rachael Jones -
A year ago
10 Aug 2018 - Biopharmaceutical company Telix Pharmaceuticals (ASX:TLX) has extended its agreement with Endocyte, Inc.
Market Reports /
by Rachael Jones -
A year ago
30 May 2018 - Australian shares closed lower today - 29 per cent lower. That's the market's lowest close since April 30. Rio (ASX:RIO) is continuing its slide from yesterday, BHP (…
Company News /
by Anna Napoli -
A year ago
30 May 2018 - Telix Pharmaceuticals (ASX:TLX) has announced a research collaboration with Osaka University.
Company Presentations /
by -
A year ago
02 May 2018 - Telix Pharmaceuticals Limited (ASX:TLX) CEO, Dr Christian Behrenbruch, presents the company’s development of diagnostic and therapeutic products based on molecularly …
Interviews /
by Rachael Jones -
A year ago
02 May 2018 - Telix Pharmaceuticals Limited (ASX:TLX) CEO, Dr Christian Behrenbruch, discusses the company’s development of diagnostic and therapeutic products based on molecularly…
Company News /
by Anna Napoli -
A year ago
10 Apr 2018 - Pharmaceutical company, Telix Pharmaceuticals (ASX:TLX) has signed a contract with US biotech company Endocyte.
Market Reports /
by Rachael Jones -
A year ago
26 Mar 2018 - The Australian share market opened lower this morning in response to heavy declines in the US but stablised throughout the day. Administrators have been called in to …
Market Reports /
by Clive Tompkins -
2 years ago
15 Nov 2017 - Market retreats after three-session high: Aus shares close 0.15% lower. Clean Seas Seafood (ASX:CSS) has successfully completed a $17.6 million capital raise. The fun…
Market Reports /
by Kathy Skantzos -
2 years ago
15 Nov 2017 - ASX dropped after a weak start from Wall Street. The drop in the iron ore price put a cap on gains. Health care and technology are performing well while the other sec…
